According to Cross Country Healthcare's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.17. At the end of 2024 the company had a P/S ratio of 0.4323.
Year | P/S ratio | Change |
---|---|---|
2024 | 0.4323 | 9.71% |
2023 | 0.3940 | 11.6% |
2022 | 0.3531 | -43.89% |
2021 | 0.6292 | 64.01% |
2020 | 0.3837 | -24.32% |
2019 | 0.5069 | 58.5% |
2018 | 0.3198 | -40.56% |
2017 | 0.5381 | -12.96% |
2016 | 0.6182 | -9.41% |
2015 | 0.6824 | 7.96% |
2014 | 0.6321 | -10.69% |
2013 | 0.7078 | 86.8% |
2012 | 0.3789 | 10.14% |
2011 | 0.3440 | -38.81% |
2010 | 0.5622 | 5.79% |
2009 | 0.5314 | 44.25% |
2008 | 0.3684 | -41.15% |
2007 | 0.6260 | -41.44% |
2006 | 1.07 | 20.81% |
2005 | 0.8849 | -2.16% |
2004 | 0.9045 | 30.42% |
2003 | 0.6935 | 0.09% |
2002 | 0.6929 |